NovaBridge Biosciences Cash Flow Reinvestment Rate
NovaBridge Biosciences cash flow reinvestment rate. NovaBridge Biosciences (NBP) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $41.00 (capex $41.00 ) from operating cash flow of $13.15 Million. Explore NBP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of NovaBridge Biosciences (2020–2020)
Cash flow reinvestment rate of NovaBridge Biosciences from 2020 to 2020. Historical reinvestment intensity for NovaBridge Biosciences across 1 annual periods. Explore NBP capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
NovaBridge Biosciences Cash Flow Reinvestment Rate by Year (2020–2020)
NovaBridge Biosciences cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for NovaBridge Biosciences. For the full cash flow conversion analysis, see NovaBridge Biosciences operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.02x | $8.01 Million | $433.56 Million | $8.01 Million | — |